Super app
Saves a ton of time. Has really changed my practice.
Super helpful
I am not a cerebrovascular surgeon but find this app very helpful when I am covering my colleagues’ patients on call.
Super!!!
The best stroke app, by far.

Access essential medical literature on cerebrovascular diseases and stroke management. Quickly review seminal studies and randomized trials in an easy-to-read format. Ideal for medical professionals and students to enhance their knowledge base.
3.3
April 12, 2026
Updates to improve reliability of downloading new references, and subscription management.
Annual subscription with a free 3 day trial.
Cerebrovascular & Stroke: WTD is a medical reference app that provides easy access to essential literature, including randomized controlled trials, on the management of cerebral aneurysms, arteriovenous malformations, and stroke. It aims to help users quickly review seminal studies and update their knowledge.
This app is designed for staff surgeons, residents, medical students, PAs, and NPs who need to quickly access and review information related to cerebrovascular diseases and stroke management.
The app covers major areas of surgical and medical management of cerebral aneurysms, arteriovenous malformations, and stroke. It includes over two hundred references and citation information for further study.
Yes, Cerebrovascular & Stroke: WTD is free to download and use. It offers an annual subscription for $1.99 which includes a 3-day free trial.
No, the app does not contain advertisements. It is free to use with an optional subscription plan.
Cerebrovascular & Stroke: WTD is available for iPhone and iPod devices. It has an age rating of 12+.
The latest version of Cerebrovascular & Stroke: WTD is 3.2.2, which was last updated on December 9, 2022. This indicates a relatively recent update cycle.
The content of Cerebrovascular & Stroke: WTD overlaps with Neurosurgery: What’s the data?, which covers a broader scope of neurosurgery. This app specifically focuses on cerebrovascular diseases and stroke.